HomeMLTX • NASDAQ
add
MoonLake Immunotherapeutics
Previous close
$54.30
Day range
$52.45 - $54.97
Year range
$31.42 - $61.87
Market cap
3.38B USD
Avg Volume
551.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 60.70M | 98.50% |
Net income | -55.22M | -127.55% |
Net profit margin | — | — |
Earnings per share | -0.87 | -123.08% |
EBITDA | -59.96M | -98.29% |
Effective tax rate | -0.17% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 425.08M | -18.22% |
Total assets | 460.10M | -15.56% |
Total liabilities | 102.15M | 588.07% |
Total equity | 357.94M | — |
Shares outstanding | 63.50M | — |
Price to book | 9.75 | — |
Return on assets | -31.24% | — |
Return on capital | -32.92% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -55.22M | -127.55% |
Cash from operations | -54.53M | -95.52% |
Cash from investing | 88.25M | 200.58% |
Cash from financing | 0.00 | — |
Net change in cash | 35.12M | 130.36% |
Free cash flow | -36.16M | -49.83% |
About
Founded
2020
Headquarters
Website
Employees
100
